Posted 28 September 2017
By Zachary Brousseau
US Food and Drug Administration Commissioner Scott Gottlieb addressed attendees of RAPS’ 2017 Regulatory Convergence on 11 September. He focused his remarks on making the clinical end of drug development more efficient and effective. If you missed it or would like to see his presentation again, the video is embedded below.